Journal profile · MICROBIOLOGY
Current Clinical Microbiology Reports
ISSN 2196-5471 · Springer Nature · 4 issues per year
Current Clinical Microbiology Reports: CAS Zone 3 · Biology (2025 upgraded edition); impact factor 4.6 (journal website); hybrid open access; APC about USD 4,790; median 81 days to acceptance (28 articles, last 24 months); 26 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Current Clinical Microbiology Reports is published by Springer Nature and is in Zone 3 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Antifungal resistance and susceptibility, Fungal Infections and Studies and Herpesvirus Infections and Treatments, together about 34.8% of its articles. Its main subfields are Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
Current Clinical Microbiology Reports commissions expert reviews from leading scientists at the forefront of research in microbiology. The journal covers this broad field by dividing it into four key main areas of study: virology, bacteriology, parasitology, and mycology. Within each of the four sections, experts from around the world address important aspects of clinical microbiology such as immunology, diagnostics, therapeutics, antibiotics and antibiotic resistance, and vaccines. Some of the world’s foremost authorities in the field of microbiology serve as section editors and editorial board members. Section editors select topics for which leading researchers are invited to contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, which are highlighted in annotated reference lists. These timely reviews of the literature examine the latest scientific discoveries and controversies as they emerge and are indispensable to both researchers and clinicians. The editorial board, composed of internationally diverse members, reviews the annual table of contents, ensures that topics address all aspects of emerging research, and where applicable suggests topics of critical importance to various countries/regions.
From the journal's Aims & Scope
Research area (LetPub): MICROBIOLOGY
Editor-in-chief Bridget BarkerPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antifungal resistance and susceptibilityMedicine15.3%
- Fungal Infections and StudiesMedicine12.3%
- Herpesvirus Infections and TreatmentsMedicine7.2%
- Cytomegalovirus and herpesvirus researchMedicine6.7%
- Gut microbiota and healthBiochemistry, Genetics and Molecular Biology3.9%
- Viral-associated cancers and disordersMedicine3.9%
- Viral gastroenteritis research and epidemiologyMedicine3.9%
- Nail Diseases and TreatmentsMedicine3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Microbiology | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Microbiology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
CASCAB AbstractsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 4.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.4Publisher website ·
- CiteScore 2026-06
- 5.4LetPub ·
- SJR 2026-06
- 1.13LetPub ·
- SNIP 2026-06
- 1.24LetPub ·
- h-index
- 43OpenAlex ·
- i10-index
- 132OpenAlex ·
- 2-year mean citedness
- 6.45OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 51.28%LetPub ·
Volume
- Articles per year
- 26LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 165,700Publisher website ·
Articles by year OpenAlex count · 275 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 16 | 5 | 5 |
| 2025 | 26 | 12 | 94 |
| 2024 | 25 | 17 | 333 |
| 2023 | 28 | 16 | 278 |
| 2022 | 10 | 8 | 157 |
| 2021 | 20 | 14 | 446 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
81 daysMedian, submission to acceptance · P25–P75 40 days – 124 days
- Acceptance to online
- median 15 days (43 articles)
- Submission to online
- median 92 days
- Sample
- 28 articles with submission and acceptance dates (44 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 4 daysPublisher website ·
- Peer review
- Double anonymous peer review, Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,790 / EUR 3,690 / GBP 2,990 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted5
- commentaryReview Articles and Invited Commentaries Back to topLength not stated
- editorialSingle-blind peer review This journal follows a single-blind reviewing procedure. Editorial Procedure—additional information This journal adheres to a standard …Length not stated
- invited commentariesReview Articles and Invited CommentariesLength not stated
- review articleReview Articles and Invited Commentaries Back to topLength not stated
- review articlesReview Articles and Invited CommentariesLength not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
LLM use policy Model summary
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
Competing interests disclosure Model summary
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Current Clinical Microbiology Reports, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Single-blind peer review Model summary
This journal follows a single-blind reviewing procedure.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Frequency
- 4 issues per year
- ISSN
- 2196-5471
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Current Clinical Microbiology Reports
What CAS zone is Current Clinical Microbiology Reports in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Clinical Microbiology Reports is in Zone 3 of Biology, and in Zone 4 of the minor category Microbiology. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Clinical Microbiology Reports?
The journal's website gives an impact factor of 4.6 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 5.4, h-index 43.
How long does peer review take at Current Clinical Microbiology Reports?
Based on the dates recorded on 28 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 81 days (interquartile range 40–124 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Current Clinical Microbiology Reports?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Current Clinical Microbiology Reports?
According to LetPub and DOAJ records, Current Clinical Microbiology Reports is indexed in ESCI and Scopus. The journal's website also lists CAS and CAB Abstracts; that list has not been checked against each database.
Is Current Clinical Microbiology Reports open access, and what is the APC?
Current Clinical Microbiology Reports is a hybrid journal. For open-access publication: APC about USD 4,790.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .